Showing results (181-190 of 197) with videos related to
Sort By:
Pageof 20
Cancer|July 1, 1992
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsH Zincke, E J Bergstralh, J J Larson-Keller, et al.Anticancer Research|June 25, 2003
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapyW M Brueckl, C Moesch, T Brabletz, et al.Anticancer Research|February 19, 2002
Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patientsW M Brueckl, J M Preuss, A Wein, et al.JAMA|September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapyA V D'Amico, R Whittington, S B Malkowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trialsA V D'Amico, R Whittington, S B Malkowicz, et al.Cancer|May 20, 1998
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapyA V D'Amico, A Desjardin, A Chung, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acidA Wein, C Riedel, F Köckerling, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Pageof 20